Drug Shortage Report for SALOFALK
| Report ID | 161258 |
| Drug Identification Number | 02242146 |
| Brand name | SALOFALK |
| Common or Proper name | mesalamine suppository |
| Company Name | APTALIS PHARMA CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | MESALAZINE |
| Strength(s) | 1G |
| Dosage form(s) | SUPPOSITORY |
| Route of administration | RECTAL RECTAL |
| Packaging size | 30s |
| ATC code | A07EC |
| ATC description | INTESTINALANTIINFLAMMATORY AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2022-05-25 |
| Actual start date | |
| Estimated end date | 2022-06-08 |
| Actual end date | 2022-06-06 |
| Shortage status | Resolved |
| Updated date | 2022-06-07 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2022-06-07 | English | Compare |
| v5 | 2022-06-06 | French | Compare |
| v4 | 2022-06-06 | English | Compare |
| v3 | 2022-05-26 | English | Compare |
| v2 | 2022-05-25 | French | Compare |
| v1 | 2022-05-25 | English | Compare |
Showing 1 to 6 of 6